EcoDrugPlus

Ensembl ID : ENSBBBG00000022328
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSBBBG00000018962
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSBBBG00000020597
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSBBBG00000020614
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSBBBG00000010992
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSBBBG00000011047
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSBBBG00000011152
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSBBBG00000019803
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSBBBG00000019768
Gene Symbol: -
Cross references: -
286 Possible Orthologues:

Ensembl ID : ENSBBBG00000024667
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSBBBG00000019781
Gene Symbol: -
Cross references: -
300 Possible Orthologues:

Ensembl ID : ENSBBBG00000019814
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).